| Current Treatment Approach in Acute Hepatitis C Infection | HATİCE RAHMET GÜNER,BİRCAN KAYAASLAN | 1–5 |
| Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals | Sibel YILDIZ KAYA,BİLGÜL METE,Abdurrahman KAYA,İLKER İNANÇ BALKAN,NEŞE SALTOĞLU,ÖMER FEHMİ TABAK | 6–9 |
| Distribution of Hepatitis C Virus Genotypes in the Region of İstanbul Northern Anatolian Association of Public Hospitals | Ülkü ORAL ZEYTİNLİ,Fatma Muhterem YÜCEL,Şölen DALDABAN DİNÇER,Özgür YANILMAZ,SEBAHAT AKSARAY,Kamil ÖZDİL | 10–13 |
| Hepatitis B Virus and Hepatitis C Virus Co-infection: An Evaluation of Eighty-Two Patients | BİLGEHAN AYGEN,ÖZGÜR GÜNAL,ORHAN YILDIZ,MUSTAFA KEMAL ÇELEN,SILA AKHAN,HÜSEYİN ŞENER BARUT,CELAL AYAZ | 14–19 |
| Kronik Hepatit B Enfeksiyonunda Şiddetli Fibrozisi Belirlemede King Skoru Daha Etkin Olabilir | Zehra KARACAER,Özgür AVCI,Fatma Yılmaz KARADAĞ | 20–25 |
| Esrar ve Opiyat Bağımlılarında Hepatit B Virüsü, Hepatit C Virüsü ve HIV Enfeksiyonları Sıklığı | Nuran KARABULUT,Zekiye ÇATAK | 26–29 |
| Determination of Resistance Mutation in Chronic Hepatitis B Patients Using Antiviral Drugs at Our Hospital | Begüm SARAN,Uğur TÜZÜNER,BAHADIR FEYZİOĞLU,MEHMET ÖZDEMİR,MAHMUT BAYKAN | 30–33 |
| Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report | MUSTAFA KEMAL ÇELEN,İREM AKDEMİR KALKAN,RECEP TEKİN,Kadim BAYAN,CELAL AYAZ | 34–36 |